On November 17th, catch John Mayer on Fuse live from the landmarked Beacon Theatre in New York City. Be the first to see world premiere performances from his brand new album \
Only 3 vehicles of more than 100 evaluated by the Insurance Institute for Highway Safety have child restraint installation hardware that earns a good rating for ease of use, while more than half have hardware that is poor or marginal.
The Institute's new LATCH ratings will serve as a resource for families looking for a vehicle that makes it easy to transport their children safely. They also are intended to encourage vehicle manufacturers to pay attention to this equipment and make improvements. Properly installed, age-appropriate child restraints provide considerably more protection for children in crashes than safety belts alone. However, observational studies have found that parents and caregivers often fail to secure them tightly or make other installation mistakes.
LATCH, which stands for Lower Anchors and Tethers for Children, is intended to make it easier to install a child seat properly. It works: Child restraints installed with LATCH, rather than with vehicle safety belts, are more likely to be installed correctly, research has shown. But in many vehicles, LATCH hardware could be better. Parents are more likely to install the seat correctly when the LATCH hardware meets certain key ease-of-use criteria.
A level IV trauma center in Washington State has installed copper components throughout its facility as another way of reducing hospital-acquired infections and keeping their patients safe.
Pullman Regional Hospital has become an early adopter of antimicrobial copper after studies found that the age-old metal could continuously kill deadly bacteria.
Each year, 2 million people in the United States are diagnosed with a hospital-acquired infection and nearly 100,000 people die. These infections are caused by common bacteria such as E. coli, MRSA, C. diff, CRE and VRE.
“It is a very serious problem,” said Ed Harrich, the director of surgical services for Pullman Regional Hospital. “I think every hospital across the nation is doing everything they can to try to deal with it the best that they can. But there’s bioburden on everything and people aren’t good at hand washing and there’s cross-contamination everywhere you go.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7378651-copper-development-association-cda-pullman-regional-hospital-keep-patients-safe-antimicrobial-copper/
https://brodmin.com/case-studies/gig-economy-case-study/
The gig economy represents a free market system in which organizations and independent workers engage in short-term work arrangements.
That is the general definition of this topic.
But how much do we know about the gig economy and why is it becoming so increasingly popular in the past few years?
We have conducted a study to examine all aspects of the gig economy to shed new light on this topic and give guidance to all professionals looking to explore freelancing.
GAC Motor’s display of its globalization drive and the latest models at the North American International Auto Show ticked all the right boxes as the leading automotive manufacturer in China built up intimacy with international customers, dealers and business partners.
GAC put its best foot forward in reinforcing its ambitions of making cars for the world as it shed the light on its go–outbound campaign during the international auto exhibition in Detroit that concluded on January 25, 2015.
“After meticulous planning and careful studies, we start to create our own brands by adopting international standards,” said Wu Song, general manager of GAC Motor. “We are confident that GAC Motor can churn out world-class vehicles to compete in the international market.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7447151-gac-motors-detroit-auto-show/
On November 17th, catch John Mayer on Fuse live from the landmarked Beacon Theatre in New York City. Be the first to see world premiere performances from his brand new album
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Soy consumption is up 14 percent since 2011,26 yet confusion lingers over soy’s role in everything from human health to food production. To clear up misperceptions, the United Soybean Board (USB) busts five common soy myths with science-backed facts on SoyConnection.com/soy-wisdom.
1) Eating soy does not increase breast cancer risk.
Clinical studies show soy isoflavone exposure does not adversely affect breast tissue as assessed by markers of breast cancer risk, such as breast cell proliferation.1–7 The American Institute for Cancer Research and the American Cancer Society say that women who have been diagnosed with breast cancer can safely consume soyfoods. In fact, the World Cancer Research Fund International has identified a link between soy consumption and an improved survival of breast cancer patients.8-9
“Not only does evidence indicate soyfoods may benefit women with breast cancer, but consuming soy when young helps prevent the onset of this disease later in life27-30,” stated Mark Messina, Ph.D., who has dedicated the past 30 years to understanding the health effects of soyfoods.
To view the multimedia release go to:
http://www.multivu.com/players/English/7877951-united-soybean-board-top-soy-myths/
Do science and religion conflict? Is there disagreement between science and spirituality? It turns out there is no conflict. The apparent conflict is because, till now, the metaphors of ancient texts such as the Bible, Talmud, and ancient Yoga Literature, had not been rigorously studied and compared to cutting edge scientific discoveries. Some of these studies have been reviewed by scientists and published in three international peer-reviewed scientific journals. Sanjay's research on the new agreements between spirituality and science is the first ever to get published in such high-ranking journals.
By Sanjay C. Patel, Author of GOD IS REAL - The Stunning New Convergence of Science and Spirituality. Visit: http://www.SanjayCPatel.com
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
The Department of Veterans Affairs will recognize 2012 National VA Research Week April 23 – 27. This year’s theme, “Caring for Veterans Through Discovery & Collaboration,” will mark a week that celebrates the contributions of Veterans who make research possible by participating in VA research studies as well as VA investigators and collaborators.
John P. Holdren, PhD, Director of the White House Office of Science and Technology Policy and Assistant to the President, will be a featured speaker at VA’s Research Week Forum April 26. The Forum, to be held at VA Central Office in Washington D.C., is part of the Department’s annual Research Week celebration. Dr. Joel Kupersmith, Chief Research and Development Officer, will provide opening remarks and serve as Forum moderator.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52323-deka-arm-veterans-2012-va-national-research-week
